There are consequences... The constant re-orgs here are getting tiresome.... Every time there is someone who will get screwed. Durin reorgs, ven if there is no headcount reduction, we spend a lot of time trying to re-define how work is being done, how things flow, who is responsible etc. So, this creates confusion and people leave.
Also, never underestimate headcount reductions - every time they reorg they are looking for cuts - this is not only here at AstraZeneca - all pharma companies are doing this...
2018 will be no different and you will see more cuts.